The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The MEK Inhibitor in Low-Grade Serous Ovarian Cancer (MILO)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician’s choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum.
Bradley J. Monk
Research Funding - Array BioPharma
Rachel N. Grisham
No relevant relationships to disclose
Christian Marth
No relevant relationships to disclose
Susana N. Banerjee
Research Funding - Array BioPharma
Felix Hilpert
No relevant relationships to disclose
Robert L. Coleman
No relevant relationships to disclose
Eric Pujade-Lauraine
No relevant relationships to disclose
Sandro Pignata
No relevant relationships to disclose
Mansoor Raza Mirza
No relevant relationships to disclose
Amit M. Oza
Research Funding - Array BioPharma
Josep M. del Campo
No relevant relationships to disclose
Martin Klaus Oehler
No relevant relationships to disclose
Adam James
Employment or Leadership Position - Array BioPharma
Stock Ownership - Array BioPharma
Janna Christy-Bittel
Employment or Leadership Position - Array BioPharma
Stock Ownership - Array BioPharma
Emma Barrett
Employment or Leadership Position - Array BioPharma
Stock Ownership - Array BioPharma
Adam P. Boyd
Employment or Leadership Position - Array BioPharma
Stock Ownership - Array BioPharma
Ignace Vergote
Consultant or Advisory Role - Array BioPharma